Clarity Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$376K Buy
314
+2
+0.6% +$2.04K 0.07% 82
2026
Q1
$287K Hold
312
0.06% 90
2025
Q4
$336K Buy
312
+6
+2% +$5.74K 0.07% 83
2025
Q3
$234K Sell
306
-2
-0.6% -$1.49K 0.05% 92
2025
Q2
$240K Buy
308
+31
+11% +$24.1K 0.06% 89
2025
Q1
$229K Sell
277
-35
-11% -$29.1K 0.06% 89
2024
Q4
$241K Sell
312
-51
-14% -$42.2K 0.07% 88
2024
Q3
$322K Buy
363
+122
+51% +$110K 0.09% 77
2024
Q2
$218K Buy
+241
New +$193K 0.07% 84

Other funds holding LLY

Clarity Wealth Advisors's LLY Position: Q2 2026 in Review

Clarity Wealth Advisors increased its Eli Lilly (LLY) stake by 0.64% in Q2 2026, buying an estimated $2.04K and bringing the position to 314 shares worth $376K. The position accounts for 0.07% of the portfolio, ranked #82.

Clarity Wealth Advisors first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Clarity Wealth Advisors held 314 shares of Eli Lilly worth $376K as of Q2 2026.
  • Clarity Wealth Advisors bought 2 Eli Lilly shares in Q2 2026, an estimated $2.04K.
  • Eli Lilly made up 0.07% of Clarity Wealth Advisors's portfolio in Q2 2026, its #82 holding.
  • Clarity Wealth Advisors first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Clarity Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.